London, UK, 15th May 2023 / Sciad Newswire / Laverock Therapeutics Ltd today announces that a key update on its proprietary
Press Release
Mon, 15/05/2023 - 00:00
Wed, 10/05/2023 - 07:30
Taipei, Taiwan, 10th May 2023 / Sciad Newswire / BRIM Biotechnology, Inc.
Thu, 04/05/2023 - 06:00
London, UK, 4th May 2023 / Sciad Newswire /
Wed, 03/05/2023 - 07:30
London, UK, 3rd May 2023 / Sciad Newswire / The RSA Group, a leading life sciences executive sea
Fri, 21/04/2023 - 08:00
Cambridge and Saffron Walden, UK, 21st April 2023 / Sciad Newswire
Tue, 18/04/2023 - 07:30
Connect in Pharma is promoting a new era of cross-sector collaboration within the pharmaceutical industry
Wed, 12/04/2023 - 12:11
Taipei, Taiwan, 6th April 2023, BRIM Biotechnology, Inc. (“BRIM,” TPEx 6885), a clinical-stage biotechnology company advancing novel regenerative peptide therapies, submitted IND today for
Thu, 23/03/2023 - 07:30
Through a series of exclusive interviews and a survey of industry insiders, Connect in Pharma names the top pharmaceutical and manufacturing-related trends of 2023.
Wed, 15/03/2023 - 07:30
Irving, United States, 15th March 2023 / Sciad Newswire /
Wed, 08/03/2023 - 07:30
THUWAL, SAUDI ARABIA, March 8th 2023 / Sciad Newswire / King Abdullah University of Science and Technology (KAUST) is launching “Dear AI,” an International Women’